Fusion Antibodies annual operating margin
2022
2023
2024
2025
Fusion Antibodies Operating Margin Growth & History (FAB)
Fusion Antibodies's operating margin was −90.53% for fiscal 2025.
View full Fusion Antibodies company overviewFusion Antibodies annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-03-31 | −90.53% | +110.79 pp |
| 2024 | 2024-03-31 | −201.32% | −102.80 pp |
| 2023 | 2023-03-31 | −98.52% | −70.91 pp |
| 2022 | 2022-03-31 | −27.61% | — |
Fusion Antibodies operating margin trends
Between the periods ended 2022-03-31 and 2025-03-31, Fusion Antibodies's operating margin decreased from −27.61% to −90.53%, a change of −62.92 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fusion Antibodies source filings ↗